EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Chimeric Antigen Receptor Cell Therapy: Empowering Treatment Strategies for Solid Tumors

Tang-Her Jaing iD, Yi-Wen Hsiao, Yi-Lun Wang iD

Current Issues in Molecular Biology · 31.01.2025 · 47 (2) · 90

DOI: 10.3390/cimb47020090 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 31.01.2025. Verfasst von Tang-Her Jaing und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Pediatrics, Chang Gung Memorial Hospital, 5 Fu-Shin Street, Kwei-Shan, Taoyuan 33315, Taiwan. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor-T (CAR-T) cell therapy has demonstrated impressive efficacy in the treatment of blood cancers; however, its effectiveness against solid tumors has been significantly limited. The differences arise from a range of difficulties linked to solid tumors, including an unfriendly tumor microenvironment, variability within the tumors, and barriers to CAR-T cell infiltration and longevity at the tumor location. Research shows that the reasons for the decreased effectiveness of CAR-T cells in treating solid tumors are not well understood, highlighting the ongoing need for strategies to address these challenges. Current strategies frequently incorporate combinatorial therapies designed to boost CAR-T cell functionality and enhance their capacity to effectively target solid tumors. However, these strategies remain in the testing phase and necessitate additional validation to assess their potential benefits. CAR-NK (natural killer), CAR-iNKT (invariant natural killer T), and CAR-M (macrophage) cell therapies are emerging as promising strategies for the treatment of solid tumors. Recent studies highlight the construction and optimization of CAR-NK cells, emphasizing their potential to overcome the unique challenges posed by the solid tumor microenvironment, such as hypoxia and metabolic barriers. This review focuses on CAR cell therapy in the treatment of solid tumors.

Schlagwörter

Stichwörter der Autor:innen

chimeric antigen receptorinvariant natural killer Tmacrophagenatural killersolid tumortumor microenvironment

Autor:innen und Institutionen

  • Division of Hematology and Oncology, Department of Pediatrics, Chang Gung Memorial Hospital, 5 Fu-Shin Street, Kwei-Shan, Taoyuan 33315, Taiwan.
  • Division of Nursing, Chang Gung Memorial Hospital, 5 Fu-Shin Street, Kwei-Shan, Taoyuan 33315, Taiwan.

ORCID-Profile: Tang-Her Jaing, Yi-Lun Wang

Zitieren

APA

Jaing, T. H., Hsiao, Y. W., & Wang, Y. L. (2025). Chimeric Antigen Receptor Cell Therapy: Empowering Treatment Strategies for Solid Tumors. Current Issues in Molecular Biology, 47(2), 90. https://doi.org/10.3390/cimb47020090

Vancouver

Jaing TH, Hsiao YW, Wang YL. Chimeric Antigen Receptor Cell Therapy: Empowering Treatment Strategies for Solid Tumors. Current Issues in Molecular Biology. 2025;47(2):90. doi:10.3390/cimb47020090

BibTeX
@article{Jaing2025,
  author = {Jaing, Tang-Her and Hsiao, Yi-Wen and Wang, Yi-Lun},
  title = {Chimeric Antigen Receptor Cell Therapy: Empowering Treatment Strategies for Solid Tumors},
  journal = {Current Issues in Molecular Biology},
  year = {2025},
  volume = {47},
  number = {2},
  pages = {90},
  doi = {10.3390/cimb47020090}
}
Kostenlos starten →